Posts
- Category: Biotech (continued)
- MannKind doubles third quarter revenue, trims loss
- Inogen beats expectations and stock soars
- De Oro Devices offers solution for freezing of gait condition
- Biotech giant Amgen bails on brain research
- Amgen buying 20 percent of BeiGene for $2.7 billion
- Amgen earnings beat expectations
- Two Central Coast technology companies raise $150 million
- Amgen cuts list price of Repatha by 60 percent
- Amgen warns investors of 'mini-tender' offer
- Dubroff: Zuckerberg plays monopoly, dodges the truth
- Amgen CFO retiring in 2020
- Amgen declares fourth-quarter dividend
- Biotech firm Arcutis gets $94.5M in funding round
- Santa Barbara investment firm and partner to launch $200 million fund
- Sienna Bio looks to bring laser hair removal product to market
- Lawsuit financing evens scales on patent protection
- Tri-county biotech upstarts struggle to maintain stock prices
- Sienna Biopharmaceuticals filing for Chapter 11 bankruptcy
- Amgen trades cash for cash flow with Otezla deal
- Dubroff: 5 reasons to pay attention to Amgen’s Otezla deal
- Judge overturns verdict upholding Repatha patents
- Amgen's stock climbs after announcing Otezla acquisition
- CSU Channel Islands students explore stem cell uses
- Cure Pharmaceutical inks deal with hemp grower Fytiko Farms
- Amgen fends off biosimilar for arthritis drug Enbrel
- Judge blocks sale of competitor for Amgen's Enbrel
- Evidation Health connects medical researchers with patient data
- MannKind triples second quarter revenues
- Sientra stock climbs despite reporting higher net losses
- Atara's net loss exceeds analyst estimates
- Goleta-based biotech Serimmune appoints new CEO
- Sienna hires financial adviser to look at raising capital
- MannKind partners with One Drop
- Analysts bullish on Amgen and stock soars
- Amgen stock up despite earnings miss for second quarter
- Atara Biotherapeutics raising $150 million in public stock offering
- Our view: Setbacks are costly but biotech industry copes
- MannKind partners with drug discount app GoodRx
- Tri-county legislators have bills pending
- Amgen discontinues Alzheimer’s prevention drug trials
- Judge blocks rule requiring drug prices to be disclosed in TV ads
- Nuevolution shareholders OK takeover by Amgen
- Europeans nix Amgen's Evenity over negative trial results
- Entrada Ventures fund aims to help grow technology startups
- Amgen partners with Institute for Protein Design
- Amgen joins lawsuit to block rule requiring drug pricing in TV ads
- Cure Pharmaceuticals may double shares of common stock
- FDA approves Amgen biosimilar Kanjinti
- Serimmune issues $1.4 million in promissory notes
- Sienna, MannKind stocks move on new trial data
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552
